# Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism

> **NCT01441557** · PHASE2,PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 3 (actual)

## Conditions studied

- Botulism

## Interventions

- **DRUG:** 3,4-diaminopyridine

## Key facts

- **NCT ID:** NCT01441557
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441557, "Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01441557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*